» Articles » PMID: 22452415

Review: a Critical Evaluation of Arguments Opposing Male Circumcision for HIV Prevention in Developed Countries

Overview
Journal AIDS Care
Publisher Informa Healthcare
Date 2012 Mar 29
PMID 22452415
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

A potential impediment to evidence-based policy development on medical male circumcision (MC) for HIV prevention in all countries worldwide is the uncritical acceptance by some of arguments used by opponents of this procedure. Here we evaluate recent opinion-pieces of 13 individuals opposed to MC. We find that these statements misrepresent good studies, selectively cite references, some containing fallacious information, and draw erroneous conclusions. In marked contrast, the scientific evidence shows MC to be a simple, low-risk procedure with very little or no adverse long-term effect on sexual function, sensitivity, sensation during arousal or overall satisfaction. Unscientific arguments have been recently used to drive ballot measures aimed at banning MC of minors in the USA, eliminate insurance coverage for medical MC for low-income families, and threaten large fines and incarceration for health care providers. Medical MC is a preventative health measure akin to immunisation, given its protective effect against HIV infection, genital cancers and various other conditions. Protection afforded by neonatal MC against a diversity of common medical conditions starts in infancy with urinary tract infections and extends throughout life. Besides protection in adulthood against acquiring HIV, MC also reduces morbidity and mortality from multiple other sexually transmitted infections (STIs) and genital cancers in men and their female sexual partners. It is estimated that over their lifetime one-third of uncircumcised males will suffer at least one foreskin-related medical condition. The scientific evidence indicates that medical MC is safe and effective. Its favourable risk/benefit ratio and cost/benefit support the advantages of medical MC.

Citing Articles

Neonatal Male Circumcision: Clearly Beneficial for Public Health or an Ethical Dilemma? A Systematic Review.

Morris B, Rivin B, Sheldon M, Krieger J Cureus. 2024; 16(2):e54772.

PMID: 38405642 PMC: 10889534. DOI: 10.7759/cureus.54772.


Evidence-based circumcision policy for Australia.

Morris B, Katelaris A, Blumenthal N, Hajoona M, Sheen A, Schrieber L J Mens Health. 2022; 18(6).

PMID: 36034719 PMC: 9409339. DOI: 10.31083/j.jomh1806132.


Critical evaluation of arguments opposing male circumcision: A systematic review.

Morris B, Moreton S, Krieger J J Evid Based Med. 2019; 12(4):263-290.

PMID: 31496128 PMC: 6899915. DOI: 10.1111/jebm.12361.


Does Male Circumcision Reduce Women's Risk of Sexually Transmitted Infections, Cervical Cancer, and Associated Conditions?.

Morris B, Hankins C, Banerjee J, Lumbers E, Mindel A, Klausner J Front Public Health. 2019; 7:4.

PMID: 30766863 PMC: 6365441. DOI: 10.3389/fpubh.2019.00004.


Re-establishing safer medical-circumcision-integrated initiation ceremonies for HIV prevention in a rural setting in Papua New Guinea. A multi-method acceptability study.

Manineng C, MacLaren D, Baigry M, Trowalle E, Muller R, Vallely A PLoS One. 2017; 12(11):e0187577.

PMID: 29117244 PMC: 5678725. DOI: 10.1371/journal.pone.0187577.


References
1.
Conroy N . "The case for boosting infant male circumcision in the face of rising heterosexual transmission of HIV" ... and now the case against. Comment. Med J Aust. 2011; 194(2):99. View

2.
Weiss H, Larke N, Halperin D, Schenker I . Complications of circumcision in male neonates, infants and children: a systematic review. BMC Urol. 2010; 10:2. PMC: 2835667. DOI: 10.1186/1471-2490-10-2. View

3.
. Male circumcision for HIV prevention in high HIV prevalence settings: what can mathematical modelling contribute to informed decision making?. PLoS Med. 2009; 6(9):e1000109. PMC: 2731851. DOI: 10.1371/journal.pmed.1000109. View

4.
Schoen E, Colby C, To T . Cost analysis of neonatal circumcision in a large health maintenance organization. J Urol. 2006; 175(3 Pt 1):1111-5. DOI: 10.1016/S0022-5347(05)00399-X. View

5.
Waldinger M, McIntosh J, Schweitzer D . A five-nation survey to assess the distribution of the intravaginal ejaculatory latency time among the general male population. J Sex Med. 2009; 6(10):2888-95. DOI: 10.1111/j.1743-6109.2009.01392.x. View